The recent development of vanadium-catalysed suppression of adipogenesis and the vast history of vanadium-mediated PTP1B inhibition and ROS generation can be carefully manipulated to target cancer stem cells, particularly breast cancer stem cells. This evidence concerns the gene PTPN1 and breast cancer.